PDF
Word
This version of the form is not currently in use and is provided for reference only. Download this version of
Form HLTH5360
for the current year.
Form HLTH5360 Pharmacare Special Authority - Request Targeted Dmards for Psoriatic Arthritis: Initial / Switch - British Columbia, Canada
Form HLTH5360 Pharmacare Special Authority - Request Targeted Dmards for Psoriatic Arthritis: Initial/Switch is a document used in the province of British Columbia, Canada, to request special authority for targeted disease-modifying antirheumatic drugs (DMARDs) for the treatment of psoriatic arthritis. It is used when initiating a new treatment or switching to a different DMARD for this specific condition.
The form HLTH5360 Pharmacare Special Authority - Request Targeted Dmards for Psoriatic Arthritis: Initial/Switch in British Columbia, Canada is to be filed by the healthcare provider or the prescribing physician on behalf of the patient.
FAQ
Q: What is HLTH5360 Pharmacare Special Authority?A: HLTH5360 Pharmacare Special Authority is a form used to request targeted DMARDs (Disease Modifying Anti-Rheumatic Drugs) for the treatment of Psoriatic Arthritis.
Q: Who can use the HLTH5360 Pharmacare Special Authority form?A: Residents of British Columbia, Canada with Psoriatic Arthritis who require targeted DMARDs can use the HLTH5360 Pharmacare Special Authority form.
Q: What does the HLTH5360 form allow?A: The HLTH5360 form allows patients to request targeted DMARDs for the treatment of Psoriatic Arthritis, either as an initial therapy or as a switch from a previous treatment.
Q: Why is special authority needed for targeted DMARDs?A: Special authority is needed for targeted DMARDs to ensure that the medication is being used appropriately and to manage costs within the healthcare system.
Download Form HLTH5360 Pharmacare Special Authority - Request Targeted Dmards for Psoriatic Arthritis: Initial / Switch - British Columbia, Canada
1
2
